SCHEMBL30008273

SCHEMBL30008273

CC(=O)OC[C@H]1O[C@@H](n2ncc3c(NOCc4ccccc4)nc(Cl)nc32)[C@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.49
ALDH1A1 P00352 1/20 0.49
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
THRB P10828 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.49
NT5E P21589 11/20 0.45
XDH P47989 1/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
POLB P06746 1/20 0.42
TSHR P16473 1/20 0.41
PRKCA P17252 1/20 0.41
AKT1 P31749 1/20 0.41
PTK2 Q05397 1/20 0.41
PRKAB2 O43741 1/20 0.40
PRKAG1 P54619 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30008321 0.90 NT5E (0.45) NT5E
SCHEMBL30008010 0.84 LMNA (0.52) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL22632225 0.83 PDE2A (0.53) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL22632207 0.82 NT5E (0.63) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL29754264 0.82 NT5E (0.63) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL30008020 0.82 LMNA (0.50) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL23007057 0.82 NT5E (0.57) NT5E
SCHEMBL23330708 0.82 LMNA (0.64) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL22628718 0.82 LMNA (0.64) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL24452562 0.82 LMNA (0.64) LMNAALDH1A1TP53MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368204-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2024-11-07 US disclosed
EP-4353732-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-04-17 EP disclosed
CN-117642411-A Small molecule CD73 antagonists and uses thereof 西藏海思科制药有限公司 2024-03-01 CN disclosed
WO-2022237747-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF 四川海思科制药有限公司 2022-11-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368204-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF ENTPD5, ENTPD1, ENTPD2 LMNA 2664/4885ALDH1A1 507/4885TP53 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.